BSE filing, NSE: STERSPN. Summary written from the filing by ALFA Finder's alert engine.
Tejassvi Aaharam Ltd: key numbers
- Share price
- ₹64.86
- Market cap
- ₹45.40 Cr
- Revenue (annual)
- ₹82.08 Cr
- Net profit (annual)
- ₹-1.00 Cr
- P/E (TTM)
- -43.2×Sector 49.5×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejassvi Aaharam Ltd
All →Tejassvi Aaharam Annual General Meeting
Tejassvi Aaharam Limited conducted its EGM to approve a name change to "WEAGRO LIMITED" and alter its objects clause. The meeting also authorized enhanced borrowing and investment powers.
Tejassvi Aaharam Capital Structure Change
Tejassvi Aaharam Ltd received trading approval from the BSE for 5,11,62,204 equity shares issued on a preferential basis, increasing the total listed equity share capital.
Tejassvi Aaharam Annual General Meeting
Tejassvi Aaharam Limited concluded its 32nd Annual General Meeting on September 30, 2026. The meeting discussed the business items listed in the prior notice.
Tejassvi Aaharam Annual General Meeting
Tejassvi Aaharam Ltd has called an Extra-Ordinary General Meeting (EGM) for 15th October 2026 to approve a company name change and alteration of its object clause.
Tejassvi Aaharam Management Change
Tejassvi Aaharam Limited appointed Adhitiyan Nagarajan as Company Secretary and Compliance Officer, effective September 21, 2026. He succeeds Abhishek Lohia, who resigned to pursue other opportunities.
Tejassvi Aaharam Board Meeting Outcome
Tejassvi Aaharam Limited announced board meeting outcomes, including the appointment of a new Company Secretary and a planned change of the company's name to "WEAGRO LIMITED".
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.